Liminal Biosciences Inc

NASDAQ:LMNL   3:59:50 PM EDT
1.11
-0.04 (-3.48%)
Earnings Announcements

Liminal Biosciences Reports Q3 Net Income Of $82.3 Mln Vs Year-Ago Loss Of $23.3 Mln

Published: 11/15/2021 23:04 GMT
Liminal Biosciences Inc (LMNL) - Liminal Biosciences Inc - Net Income Was $82.3 Million for Q3 of 2021 Compared to a Loss of $23.3 Million for Q3 of 2020.
Revenue is expected to be $0.15 Million
Adjusted EPS is expected to be -$0.32

Next Quarter Revenue Guidance is expected to be $0.56 Million
Next Quarter EPS Guidance is expected to be -$0.16

More details on our Analysts Page.